About Abl Biosciences Private Limited
Data last updated:
Abl Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the seed production and distribution segment of the agriculture sector. It was incorporated on 23 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U01403TG2012PTC082635. Its GSTIN is 36AAKCA8543K1Z8 (Telangana).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors Veeraiah Edara and Venkata Prasanna Lakshmi Edara.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No.401 Ashok Regent Eenadu Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.39 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.55 Cr (net margin 16.5%) and EBITDA of ₹3.47 Cr (EBITDA margin 36.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: ABL. As per MCA filings, the company has open charges of ₹11.63 Cr and satisfied charges of ₹5.5 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ablbiosciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFlat No.401 Ashok Regent Eenadu Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryAgriculture, Seed Production & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Abl Biosciences Private Limited
Abl Biosciences has one previous CIN (Corporate Identification Number): U01403AP2012PTC082635. The current CIN is U01403TG2012PTC082635, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01403TG2012PTC082635 | Current |
| U01403AP2012PTC082635 | Previous |
Associated Brands with Abl Biosciences Private Limited
Abl Biosciences operates one associated brand: ABL. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract research and manufacturing for biologics and vaccines are provided. | ablinc.com |
Competitors & Alternatives of Abl Biosciences Private Limited
Brands and companies operating in the same space as Abl Biosciences Private Limited include KBI Biopharma, Aldevron, Ovagen and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 KBI Biopharma | Provider of protein formulation, process & cell line development, and cGMP services | Durham, United States | 1996 |
 Aldevron | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | Fargo, United States | 1998 |
 Ovagen | Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services | Mayo, Ireland | 2000 |
 Omnia Biologics | Process development and manufacturing services for biologics are provided. | Rockville, United States | 2001 |
 Laurus Bio | Precision fermentation services for biopharma and food are provided. | Bengaluru, India | 2005 |
 Kemwell Biopharma | Integrated biologics development and manufacturing are provided as a CDMO. | Bengaluru, India | 1980 |
 Eurogentec | Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec. | Seraing, Belgium | 1985 |
 IDT Biologika | Vaccines and biologics are developed and manufactured by IDT Biologika. | Dessau Rosslau, Germany | 1921 |
 EirGenix | Biologics development and manufacturing services are offered by EirGenix. | Taipei, Taiwan | 2012 |
Business Activity of Abl Biosciences Private Limited
The main business activity of Abl Biosciences is agriculture, forestry, fishing. In detail, this covers support activities to agriculture and other activities including hunting.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Abl Biosciences Private Limited
Abl Biosciences Private Limited is audited by ANJAIAH AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANJAIAH AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Abl Biosciences Private Limited
Abl Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veeraiah Edara | Director | 23 Aug 2012 | 14 Years 1 Months | Current |
| Venkata Prasanna Lakshmi Edara | Director | 23 Aug 2012 | 14 Years 1 Months | Current |
Financials of Abl Biosciences Private Limited FY 2024 filings available
Abl Biosciences Private Limited reported revenue of ₹9.39 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Abl Biosciences Private Limited
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Abl Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.47 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.55 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Abl Biosciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 16.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Abl Biosciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Abl Biosciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Abl Biosciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2024 | Others | ₹5 Cr | Open |
| 08 Dec 2021 | Others | ₹1.03 Cr | Open |
| 22 Jun 2020 | Others | ₹53.44 Lakh | Open |
| 16 Feb 2019 | Others | ₹5.07 Cr | Open |
| 31 Oct 2014 | Icici Bank Limited | ₹5.5 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Abl Biosciences Private Limited
Abl Biosciences Private Limited has a workforce of 15 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Abl Biosciences Private Limited
Abl Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCA8543K1Z8 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Abl Biosciences Private Limited
Abl Biosciences Private Limited has 1 court case on record: 1 filed by Abl Biosciences. All case is pending. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Andhra Pradesh Industrial Infrastructure Corpn Ltd | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Abl Biosciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Abl Biosciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Abl Biosciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Abl Biosciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Abl Biosciences Private Limited
Frequently Asked Questions about Abl Biosciences Private Limited
Abl Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in seed production and distribution, within the agriculture industry. It was incorporated on 23 August 2012 (14+ years old) and is registered under CIN U01403TG2012PTC082635.
Abl Biosciences reported revenue of ₹9.39 Cr for FY 2025 (down 26% YoY).
Abl Biosciences has 2 current directors:
- Veeraiah Edara - Director
- Venkata Prasanna Lakshmi Edara - Director
Abl Biosciences reported a net profit of ₹1.55 Cr (net margin 16.5%) and EBITDA of ₹3.47 Cr (EBITDA margin 36.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Abl Biosciences is 20% over five years. In the latest year (FY 2025) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Abl Biosciences is 36AAKCA8543K1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Abl Biosciences is U01403TG2012PTC082635. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abl Biosciences has 1 court case on record: 1 filed by the company. 1 is pending.
Abl Biosciences was incorporated on 23 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.